Detalles de la búsqueda
1.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
N Engl J Med
; 385(18): 1643-1655, 2021 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449185
2.
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
Am Heart J
; 258: 17-26, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596332
3.
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Eur Heart J
; 43(33): 3100-3114, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580836
4.
Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor.
Med Princ Pract
; 32(3): 200-208, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948164
5.
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
Circulation
; 143(22): 2143-2154, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820424
6.
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
Circulation
; 144(15): 1196-1211, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455849
7.
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trial.
Am Heart J
; 252: 26-30, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671829
8.
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
Am Heart J
; 246: 32-43, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990582
9.
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
Circulation
; 142(24): 2316-2328, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33315489
10.
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
Lancet
; 393(10175): 987-997, 2019 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30827782
11.
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
N Engl J Med
; 376(13): 1234-1244, 2017 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28317428
12.
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.
Am Heart J
; 224: 10-16, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272255
13.
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
Eur Heart J
; 40(2): 180-186, 2019 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30596995
14.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J
; 209: 97-105, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703644
15.
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
Circulation
; 136(14): 1304-1314, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794001
16.
Two-year clinical outcomes of patients treated with overlapping absorb scaffolds: An analysis of the ABSORB EXTEND single-arm study.
Catheter Cardiovasc Interv
; 91(7): 1202-1209, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024452
17.
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies.
Catheter Cardiovasc Interv
; 92(2): E115-E124, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29513403
18.
Design and rationale of the COMPARE-ACUTE trial: Fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease.
Am Heart J
; 186: 21-28, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454829
19.
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
N Engl J Med
; 377(4): 397-8, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28745981
20.
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial.
Lancet
; 381(9867): 651-60, 2013 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23374650